MedTrace Logo

Diagnostic Agreement of iFR and QFR.

NCT03420131 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2018-02-05

No results posted yet for this study

Summary

A Prospective, observational, single center diagnostic study to investigate the the diagnostic agreement between QFR and the pressure wire-based iFR in a real world setting.

Conditions

Interventions

DIAGNOSTIC_TEST

QFR and iFR

iFR® (CE-Marked) is a pressure-derived, hyperemia-free index for the assessment of coronary stenosis relevance. This option consists of an FFR-iFR® specific patient interface module (PIM-FFR) which can be connected to the Volcano system - VOLCANO s5 or s5i™ platform equipped with iFR® option. QFR® (CE-Marked) is an angio-based FFR estimation using the analytical Software QAngio XA 3D from Medis medical imaging B.V., The Netherland

Sponsors & Collaborators

  • Contilia Clinical Research Institute

    lead OTHER

Principal Investigators

  • Christoph j Jensen, MD · contilia heart and vascular center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-18
Primary Completion
2018-07-28
Completion
2018-10-01

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03420131 on ClinicalTrials.gov